Vincerx Pharma Statistics
Share Statistics
Vincerx Pharma has 36.47M shares outstanding. The number of shares has increased by 70.56% in one year.
| Shares Outstanding | 36.47M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 18.09% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 27.80M |
| Failed to Deliver (FTD) Shares | 990 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 419.60K, so 1.15% of the outstanding shares have been sold short.
| Short Interest | 419.60K |
| Short % of Shares Out | 1.15% |
| Short % of Float | 1.51% |
| Short Ratio (days to cover) | 0.77 |
Valuation Ratios
The PE ratio is -0.63 and the forward PE ratio is -0.5.
| PE Ratio | -0.63 |
| Forward PE | -0.5 |
| PS Ratio | 0 |
| Forward PS | 28.3 |
| PB Ratio | 2.24 |
| P/FCF Ratio | -0.62 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Vincerx Pharma Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.
| Current Ratio | 2.63 |
| Quick Ratio | 2.63 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -3.58% and return on capital (ROIC) is -310.47%.
| Return on Equity (ROE) | -3.58% |
| Return on Assets (ROA) | -2.2% |
| Return on Capital (ROIC) | -310.47% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -956.12K |
| Employee Count | 42 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -86.82% in the last 52 weeks. The beta is 1.27, so Vincerx Pharma 's price volatility has been higher than the market average.
| Beta | 1.27 |
| 52-Week Price Change | -86.82% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.75 |
| Relative Strength Index (RSI) | 38.4 |
| Average Volume (20 Days) | 7.10M |
Income Statement
| Revenue | n/a |
| Gross Profit | -915.00K |
| Operating Income | -42.61M |
| Net Income | -40.16M |
| EBITDA | -42.61M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.89 |
Balance Sheet
The company has 12.78M in cash and 2.50M in debt, giving a net cash position of 10.28M.
| Cash & Cash Equivalents | 12.78M |
| Total Debt | 2.50M |
| Net Cash | 10.28M |
| Retained Earnings | -159.11M |
| Total Assets | 14.95M |
| Working Capital | 6.32M |
Cash Flow
In the last 12 months, operating cash flow was -40.45M and capital expenditures 0, giving a free cash flow of -40.45M.
| Operating Cash Flow | -40.45M |
| Capital Expenditures | 0 |
| Free Cash Flow | -40.45M |
| FCF Per Share | -1.9 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VINC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1111.76% |
| FCF Yield | -649.47% |
Analyst Forecast
The average price target for VINC is $2, which is 1076.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $2 |
| Price Target Difference | 1076.5% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -21.8 |
| Piotroski F-Score | 1 |